* FEATURED STUDY * Investigating Umbilical Cord-Derived Stem Cells as a Safe Treatment for Severe Lupus
A phase 1 trial conducted at Saint-Louis University Hospital (Paris) evaluated the safety of a single infusion of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in patients with severe systemic lupus erythematosus (SLE). Findings suggest the treatment was well tolerated, with no severe adverse events observed.
